Gao Zhichao, Huang Cheng, Fang Shengjie, Guan Jiaqing, Dong Weifeng
Department of Neurosurgery, The First People's Hospital of Xiaoshan District, Hangzhou, Zhejiang, China.
Department of Coloproctology, The First People's Hospital of Xiaoshan District, Hangzhou, Zhejiang, China.
Front Neurol. 2024 Jul 5;15:1394568. doi: 10.3389/fneur.2024.1394568. eCollection 2024.
White blood cell (WBC) counts has been identified as a prognostic biomarker which frequently predict adverse outcomes and mortality risk in various conditions. However, evidence for the association between WBC counts and short-term outcomes after intracranial tumor resection remains limited. This study aimed to explore associations between preoperative WBC counts and thirty-day surgical mortality after craniotomy in adult intracranial tumor patients.
This retrospective cohort study performed secondary analysis of 18,049 intracranial tumor craniotomy patients from the ACS NSQIP database (2012-2015). The major exposure and outcome were preoperative WBC counts and thirty-day surgical mortality, respectively. Cox regression modeling assessed the linear association between them. Non-linear associations between them were evaluated by conducting smooth curve fitting using an additive Cox proportional hazard model in conjunction with segmented linear regression modeling. Subgroup analysis and interaction testing assessed effect modification. Sensitivity analysis evaluated result robustness.
The total thirty-day surgical mortality after craniotomy was 2.49% (450/18,049). The mean of preoperative WBC counts was 9.501 ± 4.402 × 10^9/L. Fully adjusted model shows that elevated preoperative WBC counts was independently associated with increased thirty-day surgical mortality (HR = 1.057, 95%CI: 1.040, 1.076). Further analysis revealed a non-linear association between them: below a WBC threshold of 13.6 × 10^9/L, higher WBC counts elevated thirty-day mortality (HR = 1.117; 95%CI: 1.077, 1.158), while risk plateaued and no significant mortality rise occurred above this level (HR = 1.015, 95%CI: 0.982, 1.050). Steroid usage status has a significant effect modification on the WBC-mortality association ( for interaction = 0.002). The non-linear WBC-mortality association was only present for non-steroid users (HR = 1.158, 95%CI: 1.108, 1.210) but not steroid users (HR = 1.009, 95%CI: 0.966, 1.055). The sensitivity analysis confirmed the result robustness.
Elevated preoperative WBC counts were independently and non-linearly associated with an increased risk of thirty-day surgical mortality in adult non-steroid use patients undergoing craniotomy for intracranial tumors. As a convenient predictor, preoperative WBC data allows improved risk profiling and personalized management in adult intracranial tumor patients.
白细胞(WBC)计数已被确定为一种预后生物标志物,在各种情况下经常预测不良结局和死亡风险。然而,白细胞计数与颅内肿瘤切除术后短期结局之间关联的证据仍然有限。本研究旨在探讨成年颅内肿瘤患者开颅术前白细胞计数与术后30天手术死亡率之间的关联。
这项回顾性队列研究对来自美国外科医师学会国家外科质量改进计划(ACS NSQIP)数据库(2012 - 2015年)的18049例颅内肿瘤开颅手术患者进行了二次分析。主要暴露因素和结局分别为术前白细胞计数和术后30天手术死亡率。Cox回归模型评估二者之间的线性关联。通过使用相加Cox比例风险模型结合分段线性回归模型进行平滑曲线拟合,评估二者之间的非线性关联。亚组分析和交互作用检验评估效应修饰。敏感性分析评估结果的稳健性。
开颅术后30天手术总死亡率为2.49%(450/18049)。术前白细胞计数的平均值为9.501±4.402×10⁹/L。完全调整模型显示,术前白细胞计数升高与术后30天手术死亡率增加独立相关(风险比[HR]=1.057,95%置信区间[CI]:1.040,1.076)。进一步分析揭示二者之间存在非线性关联:在白细胞阈值13.6×10⁹/L以下,白细胞计数越高,30天死亡率越高(HR = 1.117;95%CI:1.077,1.158),而高于此水平风险趋于平稳,死亡率无显著上升(HR = 1.015,95%CI:0.982,1.050)。类固醇使用状态对白细胞与死亡率的关联有显著的效应修饰作用(交互作用P = 0.002)。白细胞与死亡率的非线性关联仅在非类固醇使用者中存在(HR = 1.158,95%CI:1.108,1.210),而在类固醇使用者中不存在(HR = 1.009,95%CI:0.966,1.055)。敏感性分析证实了结果的稳健性。
在接受颅内肿瘤开颅手术的成年非类固醇使用患者中,术前白细胞计数升高与术后30天手术死亡风险增加独立且呈非线性相关。作为一种便捷的预测指标,术前白细胞数据有助于改善成年颅内肿瘤患者的风险评估和个性化管理。